IN

INVITES BIOCORE CO., LTD

A CRO advancing precision medicine via genomic analysis and clinical trial support services.

216400 | KO

Overview

Corporate Details

ISIN(s):
KR7216400002
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로9길 33, 금천구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Invites Biocore Co., Ltd. is a biotechnology company and Contract Research Organization (CRO) established in 2001. The company specializes in supporting new drug development and advancing precision medicine. Its core services include bioanalytical testing, central lab services, clinical trial support, and genetic and cell screening, with a focus on individual genomic analysis. By leveraging advanced technology, Invites Biocore partners with domestic and international pharmaceutical companies, research institutes, and medical institutions to facilitate personalized healthcare and support the data-based bio healthcare industry throughout the R&D lifecycle.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 91.6 KB
2025-06-17 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도) (영업활동의 일부정지)
Korean 3.4 KB
2025-05-21 00:00
Regulatory News Service
주권매매거래정지 (풍문 또는 보도 관련)
Korean 5.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도)에대한답변(부인)
Korean 5.4 KB
2025-05-21 00:00
Delisting Announcement
주권매매거래정지해제 (풍문 등 조회결과 공시)
Korean 4.3 KB
2025-04-30 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정 (중간배당)
Korean 19.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.7 KB
2025-03-26 00:00
Board/Management Information
대표이사변경
Korean 10.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 15.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.1 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 200.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.3 KB

Automate Your Workflow. Get a real-time feed of all INVITES BIOCORE CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INVITES BIOCORE CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INVITES BIOCORE CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan
156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France
ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland
MDB
Medpace Holdings, Inc. Logo
Global CRO providing full-service clinical development to biotech, pharma & medical device industries.
United States of America
MEDP
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan
4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia
N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan
7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D

Talk to a Data Expert

Have a question? We'll get back to you promptly.